- GARIS PANDUAN PENGENDALIAN MEDICINES ACCESS SCHEME (MASc) DI FASILITI KKM
- List of Training Premises for Provisionally Registered Pharmacist (PRP)
- Dangerous Drugs Act 1952 and Regulations
- QUALITY MANAGEMENT SYSTEM MS ISO 9001:2015 RECERTIFICATION AUDIT 2023
- MEDICINES SUPPLY MANAGEMENT SYSTEM FOR PHARMACY VALUE ADDED SERVICES (MyUBAT)
Related FAQ
Contact Us
Lot 36,
Jalan Universiti (Jalan Prof Diraja Ungku Aziz),
46200 Petaling Jaya, Selangor.
[ Location map ]
Phone: 603-7841 3200
Fax: 603-7968 2222
You are here
Public Consultation on Comprehensive Cost-Benefit Assessment on the Medicine Pricing Policy (Preliminary Findings)
Title: Public Consultation on Comprehensive Cost-Benefit Assessment on the Medicine Pricing Policy (Preliminary Findings)
Date: 29/11/2021 - 06/12/2021
Location: Portal UPC
https://upc.mpc.gov.my/csp/sys/bi/%25cspapp.bi.work.nc.custom.regulation...
Malaysia Productivity Corporation (MPC) is currently conducting Public Consultation on Comprehensive Cost-Benefit Assessment on the Medicine Pricing Policy (Preliminary Findings). The purpose of this consultation is to seek the feedback of interested parties on the report, particularly the preliminary findings of the cost-benefit assessment on the proposed medicine pricing policy before the consultant finalizes their analysis.
All stakeholders are invited to submit comments and join the survey through the attached link.
By,
Medicines Price Management Branch.
Pharmacy Practice and Development Division
- 817 reads